452 related articles for article (PubMed ID: 22342390)
1. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
Lee BJ; Huang YC; Chen SJ; Lin PT
Nutrition; 2012 Jul; 28(7-8):767-72. PubMed ID: 22342390
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
Lee BJ; Huang YC; Chen SJ; Lin PT
Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
[TBL] [Abstract][Full Text] [Related]
3. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial.
Lee BJ; Tseng YF; Yen CH; Lin PT
Nutr J; 2013 Nov; 12(1):142. PubMed ID: 24192015
[TBL] [Abstract][Full Text] [Related]
4. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial.
Liu HT; Huang YC; Cheng SB; Huang YT; Lin PT
Nutr J; 2016 Oct; 15(1):85. PubMed ID: 27716246
[TBL] [Abstract][Full Text] [Related]
5. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
Lee BJ; Lin JS; Lin YC; Lin PT
Nutrition; 2015 Mar; 31(3):475-9. PubMed ID: 25701337
[TBL] [Abstract][Full Text] [Related]
6. A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease.
Lee BJ; Yen CH; Hsu HC; Lin JY; Hsia S; Lin PT
Nutr Res; 2012 Oct; 32(10):751-6. PubMed ID: 23146771
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Khodadadi B; Jazayeri S; Gohari MR; Aryaeian N
Nutr Neurosci; 2015 May; 18(4):169-76. PubMed ID: 24621064
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
9. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
10. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men.
Gökbel H; Gergerlioğlu HS; Okudan N; Gül I; Büyükbaş S; Belviranli M
J Med Food; 2010 Feb; 13(1):216-8. PubMed ID: 20136458
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 and Oxidative Stress: Inflammation Status in Hepatocellular Carcinoma Patients after Surgery.
Liu HT; Cheng SB; Huang YC; Huang YT; Lin PT
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28054958
[TBL] [Abstract][Full Text] [Related]
12. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
14. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease.
Michalsen A; Lehmann N; Pithan C; Knoblauch NT; Moebus S; Kannenberg F; Binder L; Budde T; Dobos GJ
Eur J Clin Nutr; 2006 Apr; 60(4):478-85. PubMed ID: 16306923
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
[TBL] [Abstract][Full Text] [Related]
16. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
17. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
Schroecksnadel K; Grammer TB; Boehm BO; März W; Fuchs D
Thromb Haemost; 2010 May; 103(5):926-35. PubMed ID: 20216983
[TBL] [Abstract][Full Text] [Related]
18. Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Wang G; Mao JM; Wang X; Zhang FC
Chin Med J (Engl); 2004 Nov; 117(11):1650-4. PubMed ID: 15569480
[TBL] [Abstract][Full Text] [Related]
19. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
20. Role of superoxide dismutase in vascular inflammation and in coronary artery disease.
Lubrano V; Di Cecco P; Zucchelli GC
Clin Exp Med; 2006 Jun; 6(2):84-8. PubMed ID: 16820996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
